Vireo Growth
OTC: VREOF
$9.78 ▼ -0.03  (-0.31%)
At close: Jul 23, 2026 · 4:00 PM UTC
Financial Ratios
Market Cap10.53 Bn
P/E-211.34
P/S30.06
Div. Yield0.00
ROIC (Qtr)0.00
Total Debt (Qtr)198.60 Mn
Revenue Growth (1y) (Qtr)333.47
Add ratio to table…

About

Vireo Growth Inc. is a vertically integrated cannabis company operating in the United States cannabis industry. The company cultivates, manufactures, and distributes cannabis products through its license-holding subsidiaries in six states. Its operations include greenhouse and indoor cultivation facilities, extraction and processing laboratories, and retail dispensaries under brands such as Green Goods™ and other Vireo Growth branded stores. The company serves both medical…

Read more ↓
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic CIK: 0001771706

Peer Comparison

Companies in the Drug Manufacturers - Specialty & Generic
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 HLN Haleon plc 88.07 Bn103.296.0011.45 Bn
2 TEVA Teva Pharmaceutical Industries Ltd 35.75 Bn23.022.0616.63 Bn
3 ZTS Zoetis Inc. 31.84 Bn12.053.359.05 Bn
4 TAK Takeda Pharmaceutical Co Ltd 27.18 Bn-10.290.5928.76 Bn
5 UTHR UNITED THERAPEUTICS Corp 23.09 Bn17.937.28-
6 RDHL RedHill Biopharma Ltd. 21.32 Bn2,931.662.24-
7 VTRS Viatris Inc 19.96 Bn-67.321.3714.34 Bn
8 NBIX Neurocrine Biosciences Inc 17.66 Bn26.415.69-